Bruce L. A. Carter, Director at Mirati Therapeutics, Inc. (MRTX), sold 20,000 shares at $85.96 ($1.7M) on 2022-08-12, disclosed to the SEC on 2022-08-16.
Open-market sale of $1.7M MRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.04 | 5,107 | $434K | 25.4% |
| 2 | $85.04 | 5,107 | $434K | 25.4% |
| 3 | $85.96 | 4,893 | $421K | 24.6% |
| 4 | $85.96 | 4,893 | $421K | 24.6% |
| Total | $85.49 avg | 20,000 | $1.7M | 100% |
| Filing → |
| MRTX | SELL | 2021-02-03 | $430K | — | Filing → |
| MRTX | SELL | 2020-12-16 | $1.1M | — | Filing → |
| MRTX | SELL | 2020-08-13 | $378K | — | Filing → |